Tg Therapeutics (TGTX) Operating Expenses (2016 - 2025)
Historic Operating Expenses for Tg Therapeutics (TGTX) over the last 10 years, with Q3 2025 value amounting to $132.3 million.
- Tg Therapeutics' Operating Expenses rose 8523.9% to $132.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $429.1 million, marking a year-over-year increase of 6175.16%. This contributed to the annual value of $287.1 million for FY2024, which is 3475.86% up from last year.
- Per Tg Therapeutics' latest filing, its Operating Expenses stood at $132.3 million for Q3 2025, which was up 8523.9% from $106.3 million recorded in Q2 2025.
- In the past 5 years, Tg Therapeutics' Operating Expenses ranged from a high of $132.3 million in Q3 2025 and a low of $35.1 million during Q3 2022
- Over the past 5 years, Tg Therapeutics' median Operating Expenses value was $72.7 million (recorded in 2024), while the average stood at $74.9 million.
- Per our database at Business Quant, Tg Therapeutics' Operating Expenses crashed by 5977.76% in 2022 and then skyrocketed by 8523.9% in 2025.
- Over the past 5 years, Tg Therapeutics' Operating Expenses (Quarter) stood at $95.3 million in 2021, then dropped by 18.53% to $77.6 million in 2022, then fell by 27.27% to $56.5 million in 2023, then skyrocketed by 38.58% to $78.2 million in 2024, then skyrocketed by 69.16% to $132.3 million in 2025.
- Its Operating Expenses was $132.3 million in Q3 2025, compared to $106.3 million in Q2 2025 and $112.2 million in Q1 2025.